Denali Therapeutics
DNLI
DNLI
202 hedge funds and large institutions have $2.49B invested in Denali Therapeutics in 2023 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 92 increasing their positions, 51 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
15% less capital invested
Capital invested by funds: $2.93B → $2.49B (-$441M)
91% less call options, than puts
Call options by funds: $999K | Put options by funds: $11.1M
Holders
202
Holding in Top 10
3
Calls
$999K
Puts
$11.1M
Top Buyers
| 1 | +$30.9M | |
| 2 | +$11.6M | |
| 3 | +$8.75M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.31M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$7.22M |
Top Sellers
| 1 | -$25.8M | |
| 2 | -$25.3M | |
| 3 | -$14.1M | |
| 4 |
CM
Crestline Management
Fort Worth,
Texas
|
-$10.4M |
| 5 |
State Street
Boston,
Massachusetts
|
-$5.86M |